AMICUS THERAPEUTICS, INC.
Biotechnology company developing therapies for rare genetic and devastating diseases.
FOLD | US
Overview
Corporate Details
- ISIN(s):
- US03152W1099
- LEI:
- Country:
- United States of America
- Address:
- 47 HULFISH STREET, 8542 PRINCETON
- Website:
- https://www.amicusrx.com/
- Sector:
- Manufacturing
Description
Amicus Therapeutics, Inc. is a global, patient-dedicated biotechnology company focused on discovering, developing, and delivering advanced therapies for people living with rare and devastating diseases. The company leverages innovative technology platforms to create high-quality medicines that address unmet medical needs in human genetic disorders. Its primary areas of focus include the research and commercialization of treatments for conditions such as Fabry disease and Pompe disease. Amicus Therapeutics is committed to being at the forefront of therapeutic development for rare metabolic diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all AMICUS THERAPEUTICS, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for AMICUS THERAPEUTICS, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for AMICUS THERAPEUTICS, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
